Drug Law Weekly

Drug Development - Cancer researcher calls for faster drug development

Eli Lilly and Co. - Alimta showed advances over Taxotere in second-line lung cancer study

Eli Lilly and Company - Program helps patients on antipsychotic drugs reduce weight

Eli Lilly and Company - Symbyax reduces suicidal ideation symptoms in bipolar depression, studies show

Emergency Medicine - EDs see dramatic increase in people with mental illness seeking care

Food Safety - Two macrolide animal antibiotics pose low risk to human health, research shows

Fox Chase Cancer Center - Research shows kidney cancer can be diagnosed in urine

Free University of Brussels - "Nanobodies" herald a new era in chemotherapeutics

Fundacion Instituto de Inmunologia de Colombia - Displacement in 6725 SERA peptide analogue protects against malaria

German Cancer Research Center - Immunotherapy for cancer: Inflammations open up access to tumors

Glasgow Royal Infirmary - Multiple trials in Europe are studying optimum statin therapy regimens

HIV/AIDS - International partnership fighting HIV/AIDS in Uganda

HIV/AIDS Privacy - Hospital, couple settle privacy suit over HIV disclosure

Hamilton Regional Cancer Centre - Radiotherapy in resected non-small cell lung cancer reviewed

Heinrich-Heine-Universitat - MEK inhibition impairs influenza virus without emergence of resistance

Hemispherx Biopharma, Inc. - Phase III Ampligen trial meets primary endpoint for CFS

Henry Ford Sleep Disorders Center - Eszopiclone improves sleep and daytime function in insomnia study

Hopital St-Louis - Neutralizing antibodies against HIV-1 tat antigen characterized

IMPAX Laboratories, Inc. - Specialty pharmaceutical has first profitable quarter driven by record revenues

Imperial College of Science, Technology, and Med. - Isonicotinic acid hydrazide inhibits malaria transmission in mosquito

Inamed Corporation - Botulinum toxin type A clinical development program advances

Incyte Corp., Palo Alto - Novel splice variant mRNAs from known drug target genes cloned

Mayo Clinic - Avian influenza may be new pandemic threat

Medicare Fraud - Company says Kentucky county defrauded Medicare program

Mylan Laboratories, Inc. - NDA submitted for nebivolol

Novartis Pharmaceuticals Corp. - FDA updates Zelnorm labeling with new risk information

Nutrition 21 - Study: Chromium picolinate is safe

Pivotal BioSciences, Inc. - Collaboration to develop PB1 mutant IL-2 cancer therapeutic

Progen Industries Limited - FDA grants Orphan Drug Status to PI-88 for treatment of melanoma

U.S. Food & Drug Administration - 4-methylthio-1-butyl group protects phosphate/thiophosphate groups

U.S. Food & Drug Administration - Arsenic determined in infant food products by IC-ICP-MS

U.S. Food & Drug Administration - CpG oligodeoxynucleotides find immunotherapeutic use

U.S. Food & Drug Administration - Levels of aristolochic acids in Chinese herbs determined by NMR

U.S. National Institutes of Health - Advances in molecular carcinogenesis reviewed

U.S. National Institutes of Health - New modeling grants target epidemics, bioterror

Wyeth - FDA approves recombinant protein device for tibia fractures in adults